The key molecular mechanism involves excess fibroblast growth factor 23 (FGF23) production, a phosphatonin first identified in autosomal dominant hypophosphatemic rickets (3) and tumor-induced osteomalacia (4, 5). The gene discussed is FGF23; the disease is autosomal dominant hypophosphatemic rickets.